Master data| INID | Criterion | Field | Content |
|---|
| Type of IP right | SART | Patent |
| Status | ST | Not pending/lapsed |
| 21 | DE file number | DAKZ | 600 11 710.3 |
| 96 | EP file number | EAKZ | 00 30 4611.7 |
| 97 | EP publication number | EPN | 1057480 |
| 54 | Designation/title | TI | Transdermale Östrogen Agonist-Antagonist Therapie |
| 51 | IPC main class | ICM
(ICMV) | A61K 9/70 (2006.01) |
| 51 | IPC secondary class(es) | ICS
(ICSV) | A61K 31/40 (2006.01), A61P 5/32 (2006.01), A61K 31/439 (2006.01), A61K 31/445 (2006.01) |
| 22 | DE application date | DAT | May 30, 2000 |
| 96 | EP application date | EAT | May 30, 2000 |
| 43 | Date of first publication | OT | Dec 6, 2000 |
| Date of publication of grant | PET | Jun 23, 2004 |
| 71/73 | Applicant/owner | INH | Pfizer Products Inc., Groton, Conn., US |
| 72 | Inventor | IN | Da Silva-Jardine, Paul Andrew, Groton, Connecticut 06340, US |
| 74 | Representative | VTR | Lederer & Keller Patentanwälte Partnerschaft mbB, 80538 München, DE |
| 10 | Published DE documents | DEPN | Original document:
DE000060011710T2
Searchable text:
DE000060011710T2 |
| Address for service | | Lederer & Keller Patentanwälte Partnerschaft mbB, 80538 München, DE |
33
31
32
| Foreign priority | PRC
PRNA
PRDA
| US
137164 P
Jun 1, 1999
|
| Patent division in charge | | 44 |
| 97 | EP language of publication | ELANG | EN - Englisch |
| 84 | Designated EP contracting states | EDS | AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE |
| 43 | Date of first publication | EVT | Dec 6, 2000 |
| Date of the first transfer into DPMAregister | EREGT | Sep 28, 2012 |
| Date of the (most recent) update in DPMAregister | REGT | Mar 27, 2015
(Show all update days)(Hide all update days)- Mar 27, 2015; Jan 22, 2013
- Historical data not available for this/these date(s)
- Sep 28, 2012
- Date of the first transfer into DPMAregister
|
